PGC-1α Is a Master Regulator of Mitochondrial Lifecycle and ROS Stress Response.
Abu Shelbayeh O, Arroum T, Morris S, Busch KB. · 2023
Read PGC-1α Is a Master Regulator of Mitochondrial Lifecycle and ROS Stress Response. by Abu Shelbayeh O, Arroum T, Morris S, Busch KB. (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc10215733.txt.
Introduction
Abu Shelbayeh and co-authors review PGC-1 alpha, a master regulator of the mitochondrial life cycle and stress response, in a 2023 paper. Mitochondria are the cell's powerhouses, and they both produce and suffer damage from reactive oxygen species. PGC-1 alpha is a switch protein that coordinates energy use and mitochondrial renewal.
The review explains how the protein responds to exercise, cold, and cell stress. It covers its role in building new mitochondria and in defending against damage. The paper links this one regulator to metabolism and aging. It also links it to disease.
Catalog record
| CREATOR | Abu Shelbayeh O, Arroum T, Morris S, Busch KB. |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 97 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
PGC-1α Is a Master Regulator of Mitochondrial Lifecycle and ROS Stress Response By Othman Abu Shelbayeh, Tasnim Arroum, Silke Morris, Karin B Busch, Gina Cavaliere, Maria Pina Mollica, Giovanna Trinchese Published in: Antioxidants DOI: 10.3390/antiox12051075 ABSTRACT Abstract Mitochondria play a major role in ROS production and defense during their life cycle. The transcriptional activator PGC-1α is a key player in the homeostasis of energy metabolism and is therefore closely linked to mitochondrial function. PGC-1α responds to environmental and intracellular conditions and is regulated by SIRT1/3, TFAM, and AMPK, which are also important regulators of mitochondrial biogenesis and function. In this review, we highlight the functions and regulatory mechanisms of PGC-1α within this framework, with a focus on its involvement in the mitochondrial lifecycle and ROS metabolism. As an example, we show the role of PGC-1α in ROS scavenging under inflammatory conditions. Interestingly, PGC-1α and the stress response factor NF-κB, which regulates the immune response, are reciprocally regulated. During inflammation, NF-κB reduces PGC-1α expression and activity. Low PGC-1α activity leads to the downregulation of antioxidant target genes resulting in oxidative stress. Additionally, low PGC-1α levels and concomitant oxidative stress promote NF-κB activity, which exacerbates the inflammatory response. Keywords: PGC-1α, ROS defense, mitonuclear communication, mitochondrial life cycle 1. INTRODUCTION The peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α is described as the master regulator of mitochondrial biogenesis and function. It was identified together with the peroxisome proliferator-activated receptor γ (PPARγ) transcription factor in mitochondria-rich and thermogenesis-specialized brown adipose tissue (BAT). Current studies suggest a role of PGC-1α in the regulation of oxidative phosphorylation (OXPHOS), fatty acid (FA)/lipid metabolism, and the modulation of reactive oxygen species (ROS). PGC-1α is found mainly in metabolically active tissues, such as the liver, kidney, skeletal muscle, brain, and adipose tissue [1,2,3]. It is also involved in the transformation of white adipose tissue into brown adipose tissue [4]. In mammals, fasting, exercise, and cold are associated with an increase in PGC-1α levels [5,6,7]. PGC-1α subsequently upregulates respiratory gene expression in the mitochondria [8]. PGC-1α belongs to the so-called PGC family of transcriptional regulators. Other members of the family are PGC-1β and PRC (PGC-1-related coactivator). The human PGC-1α consists of 798 amino acids, has a molecular weight of 91 kDa, and can be divided into several functional regions, such as the activation domain, inactivation domain, short serine/arginine-rich stretches (RS) domain, and the RNA recognition motif (RRM) [7,9] (Figure 1A). Its structure is not resolved yet. PGC-1 family members do not have a DNA-binding domain. Also, PGC-1α does not have an intrinsic histone acetyltransferase activity, which is present in other transcriptional coactivators, that initiates gene transcription and chromatin remodeling. PGC-1α acts more as a transcriptional regulator by providing a docking platform for proteins that possess histone acetyltransferase activity. Therefore, PGC-1α indirectly promotes transcription [10,11]. [Figure: Sequence, putative structure, and interactions of PGC-1α. (A) Domains and structure of PGC-1α. Structure generated with α-fold [12,13]. (B) Known and experimental interactions of the PGC-1α/PPARGC with proteins based on the STRING database entries (https://string-db.org, accessed on 11 October 2022). Created with BioRender.com, agreement No: XW25C9KJWR.] Three LXXLL leucine-rich motifs (NR boxes) are located at the N-terminal of PGC-1α’s activation region and its adjacent inactive region. These can bind to several nuclear receptors, such as NR, peroxisome proliferator-activated receptor α (PPARα), estrogen receptor (ER), or nuclear respiratory factor 1 and 2 (NRF-1/NRF-2) (Figure 1B) [14,15,16]. The serine/arginine-rich domain (RS) and the RNA processing domain (RRM) motifs towards the C-terminus are typical for proteins involved in RNA splicing [17,18]. Monsalve et al. showed in in vitro studies that the C-terminal functional region participates in mRNA(messenger RNA) processing to regulate gene expression. Mutations in the RS and RRM motifs of PGC-1α affect PGC-1α’s ability to interact with transcription factors and thus impair gene transcription [19]. 2. REGULATION OF PGC-1Α 2.1. Splice Variants of PGC-1α PGC-1α gene transcription is regulated by multiple promoter regions and is coupled with alternative splicing, resulting in a variety of PGC-1α protein variants [20]. The combination of alternative splicing and alternative use of promoters is a common process for increasing transcriptome complexity [21]. New splice variants are generated by transcription from an evolutionarily conserved alternative promoter (AP), which was found approximately 14 kb upstream of PGC-1α’s transcription start site (TSS) [22]. The transcripts of this AP contain a new exon 1 (exon 1b) with two splicing options, resulting in proteins with two different amino termini (PGC-1α-b, 12 aa long and PGC-1α-c, 3 aa long). This exon is shorter than the proximal exon 1a, which encodes for a 16 aa-long N-terminus [22,23]. The newly discovered isoforms were found in skeletal muscle after exercise [24,25,26,27] and apparently, their generation is more responsive to stimulation. Studies with PGC-1α-b in the skeletal muscle of transgenic mice revealed that a change in the mitochondrial volume is directly correlated with an improvement in exercise performance and oxidative capacity [28]. Nevertheless, the structure and function of PGC-1α-b and PGC-1α-c do not differ notably from the canonical PGC-1α [22,23]. In addition to the AP and its resulting isoforms, further TSSs and tissue-specific promoters have been described for PGC-1α in the liver, kidney, and brain. These isoforms need to be studied in a tissue-specific context and may vary functionally and structurally from the canonical PGC-1α [29,30,31]. 2.2. Regulation of the Master Regulator PGC-1α is tightly regulated at two different levels: Firstly, PGC-1α is regulated at the transcriptional level (see also Section 2.1) through several transcription factors and various extracellular stimuli such as insulin/glucagon levels, Ca2+, temperature, or exercise via signaling cascades. Secondly, PGC-1α is regulated at the posttranslational level through numerous modifications, such as acetylation, phosphorylation, methylation, or ubiquitination [32,33]. The overview in Figure 2 shows the most important signaling routes that target PGC-1α through posttranslational and transcriptional modifications. 2.3. Stress-Related Transcriptional Regulation of PGC-1α Various factors play a role in the regulation of PGC-1α, e.g., the transcription of PGC-1α is upregulated by forkhead box class-01 (FoxO1), myocyte enhancer factor 2 (MEF2), activating transcription factor 2 (ATF2), and cyclic AMP response element-binding protein (CREB). These upstream factors are induced by several extracellular stimuli such as stress, exercise, or cytokines [32,34]. Early-phase mediators of inflammation, such as the tumor necrosis factor α (TNFα), interleukin-4, and interferon-γ, regulate PGC-1α gene expression. Nuclear factor-kappa B (NF-κB), mitogen-activated protein kinase (MAPK), or Akt serine/threonine kinase (protein kinase B; Akt; PKB) have a mediating effect on these signaling pathways as well [35]. The relationship between cytokine signaling and PGC-1α in the context of inflammation will be discussed in detail in Section 4.1. [Figure: Overview of the effectors of PGC-1α. (A) Posttranscriptional control of PGC-1α. The upregulators are in green boxes, while the downregulators are shown in yellow color. Transcription factors that control PGC-1α gene expression are printed in bold. The posttranslational mediators are in light blue. Reprinted/adapted with permission from Ref. [36]. Copyright year 2021, copyright owner’s name Taylor and Francis, Licence No: 5532960029681. Adapted from Hyttinen et al., 2021 [36]. (B) Posttranslational modifications of PGC-1α. Several sites for modifications including phosphorylation, acetylation, methylation, ubiquitination, O-GlcNAcylation (O-linked N-acetyl glucosylation), and SUMOylation have been described for PGC-1α. Red molecules indicate inactivation, and blue indicates activation. Adapted from Fernandez-Marcos and Auwerx, 2011 [32]. Created with BioRender.com, agreement No: NJ25C9I2WL.] p38